Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
Launched by UNIVERSITY HOSPITAL CENTER OF MARTINIQUE · Jun 30, 2021
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how common Helicobacter Pylori infection is among people who have recently been diagnosed with stomach cancer in the West Indies. Helicobacter Pylori is a type of bacteria that can lead to stomach problems, and this study aims to understand its role in stomach cancer, which is more frequently seen in the West Indies compared to France. Researchers will collect samples of tumor tissues, healthy tissues, and blood to help identify other risk factors related to this type of cancer, especially environmental influences.
To participate, individuals must be over 18 years old, have been living in Martinique for at least six months, and have a confirmed diagnosis of stomach cancer. They should also be able to read the information provided and agree to take part in the study. Participants can expect to answer questionnaires and provide samples for research, which will contribute to better understanding and prevention of stomach cancer in the future. It's also important to note that the trial is not yet recruiting participants, so those interested will need to wait for it to start.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer
- • 2. Patient having read the information note and having signed the consent to participate in the study
- • 3. Patient with social security coverage
- Exclusion Criteria:
- • 1. Refusal to participate
- • 2. Patient who could not answer the questionnaires
- • 3. Patient not affiliated to a social security system
- • 4. Patient not fluent in French
- • 5. Patient under legal protection (legal protection, guardianship, curators, etc.)
About University Hospital Center Of Martinique
The University Hospital Center of Martinique (CHUM) is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic hospital, CHUM integrates cutting-edge research with clinical practice, fostering collaborations among healthcare professionals, researchers, and academic partners. The center is committed to enhancing health outcomes in the Caribbean region by focusing on a diverse range of medical disciplines, ensuring the highest standards of ethical conduct and patient safety in all trials. Through its comprehensive approach, CHUM aims to contribute significantly to medical knowledge and the development of effective treatment options for various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort De France, , Martinique
Patients applied
Trial Officials
Clarisse JOACHIM-CONTARET
Principal Investigator
CHU Martinique
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials